Physician profile
Joseph C Smith
NPI 1780665307
$2,167.25
in general payments reported to CMS, 2019-2025
15 companies · $613 in 2025
The $613 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $314 · 2020: $160 · 2021: $223 · 2022: $419 · 2023: $152 · 2024: $287 · 2025: $613.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,051.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $634.38 | 2019-2025 | Puraply Wound Matrix, Affinity, Affinity |
| Treace Medical Concepts, INC. | $191.64 | 2021 | |
| Novus Surgical Solutions LLC | $185.60 | 2022 | |
| Smith+Nephew, INC. | $170.57 | 2024-2025 | Stravix Pl, Grafix Pl, Stravix |
| Zimmer Biomet Holdings, INC. | $142.50 | 2019-2020 | |
| Novus Surgical Consultants | $139.04 | 2024 | |
| Bsn Medical INC | $133.54 | 2025 | |
| Medline Industries LP | $128.10 | 2025 | |
| Paratek Pharmaceuticals, INC. | $124.00 | 2022 | |
| Stryker Corporation | $99.27 | 2019-2022 | |
| Tei Medical INC. | $97.95 | 2019 | |
| Paragon 28, INC. | $52.87 | 2024 | Portfolio |
| Alfasigma USA, INC. | $31.80 | 2021 | |
| Kci USA, INC. | $19.53 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $16.46 | 2023 | Seglentis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.